I
InDex Pharmaceuticals Holding AB
STO:FLERIE
InDex Pharmaceuticals Holding AB
STO:FLERIE
Price:
27.6
SEK
-0.72%
Market Closed
Market Cap:
kr2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
SE |
|
Svenska Cellulosa SCA AB
STO:SCA B
|
SE |
|
Quisitive Technology Solutions Inc
XTSX:QUIS
|
CA |
Income Statement
Earnings Waterfall
InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB
Income Statement
InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB
Currency: SEK
| Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-10%
|
0
-7%
|
0
-3%
|
0
-6%
|
0
-6%
|
0
-25%
|
0
+24%
|
0
-14%
|
0
+5%
|
0
+2%
|
0
-14%
|
0
-9%
|
0
+9%
|
0
-19%
|
0
-19%
|
0
-1%
|
0
-43%
|
0
-13%
|
0
-49%
|
0
-50%
|
0
-56%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
98
N/A
|
98
N/A
|
98
N/A
|
98
N/A
|
0
-100%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(3)
|
(6)
|
(14)
|
(13)
|
(12)
|
(9)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(4)
|
(10)
|
(17)
|
(17)
|
(47)
|
(8)
|
(2)
|
(6)
|
(102)
|
(15)
|
(24)
|
(20)
|
(137)
|
(50)
|
(60)
|
(97)
|
(177)
|
(141)
|
(127)
|
(92)
|
(20)
|
(21)
|
(21)
|
(21)
|
(20)
|
|
| Gross Profit |
(2)
N/A
|
(3)
-36%
|
(6)
-136%
|
(14)
-129%
|
(13)
+10%
|
(12)
+3%
|
(9)
+27%
|
(1)
+90%
|
(1)
+23%
|
(0)
+34%
|
(0)
+4%
|
(0)
+36%
|
(0)
+50%
|
(0)
+68%
|
(4)
-8 570%
|
(10)
-158%
|
(17)
-68%
|
(17)
0%
|
(47)
-183%
|
(8)
+83%
|
(2)
+77%
|
(6)
-229%
|
(102)
-1 536%
|
(15)
+86%
|
(24)
-64%
|
(20)
+16%
|
(137)
-580%
|
(50)
+63%
|
38
N/A
|
1
-99%
|
(80)
N/A
|
(43)
+46%
|
(127)
-192%
|
(92)
+28%
|
(20)
+79%
|
(21)
-6%
|
(21)
-2%
|
(21)
0%
|
(20)
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(29)
|
(27)
|
(33)
|
(41)
|
(48)
|
(55)
|
(64)
|
(69)
|
(80)
|
(82)
|
(82)
|
(80)
|
(72)
|
(84)
|
(84)
|
(85)
|
(76)
|
(56)
|
(10)
|
(35)
|
(68)
|
(84)
|
(1)
|
(98)
|
(86)
|
(67)
|
34
|
(97)
|
(55)
|
(55)
|
(27)
|
(21)
|
(113)
|
(112)
|
(87)
|
(89)
|
(7)
|
(8)
|
(12)
|
|
| Selling, General & Administrative |
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(13)
|
(12)
|
(12)
|
(13)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(14)
|
(18)
|
(18)
|
(13)
|
(15)
|
(12)
|
(13)
|
(15)
|
(15)
|
(23)
|
(23)
|
(21)
|
(24)
|
(18)
|
(20)
|
(22)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
(19)
|
(18)
|
(24)
|
(31)
|
(38)
|
(45)
|
(54)
|
(59)
|
(70)
|
(72)
|
(71)
|
(70)
|
(62)
|
(74)
|
(70)
|
(71)
|
(62)
|
(42)
|
0
|
(23)
|
(56)
|
(72)
|
13
|
(83)
|
(67)
|
(47)
|
48
|
(81)
|
(42)
|
(41)
|
(12)
|
(5)
|
(89)
|
(88)
|
(65)
|
(64)
|
12
|
13
|
10
|
|
| Operating Income |
(31)
N/A
|
(30)
+3%
|
(40)
-33%
|
(55)
-38%
|
(60)
-11%
|
(67)
-11%
|
(73)
-9%
|
(70)
+4%
|
(81)
-15%
|
(82)
-2%
|
(82)
+1%
|
(81)
+2%
|
(72)
+10%
|
(84)
-17%
|
(88)
-4%
|
(95)
-8%
|
(92)
+2%
|
(73)
+21%
|
(57)
+21%
|
(43)
+26%
|
(70)
-63%
|
(90)
-29%
|
(103)
-14%
|
(112)
-9%
|
(110)
+2%
|
(87)
+22%
|
(103)
-19%
|
(147)
-43%
|
(17)
+88%
|
(55)
-220%
|
(107)
-96%
|
(65)
+40%
|
(240)
-271%
|
(204)
+15%
|
(106)
+48%
|
(110)
-4%
|
(28)
+74%
|
(29)
-3%
|
(32)
-12%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
3
|
5
|
8
|
12
|
12
|
(133)
|
42
|
(79)
|
(126)
|
(182)
|
(181)
|
(182)
|
(644)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
7
|
7
|
8
|
30
|
21
|
5
|
6
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
0
|
(10)
|
(8)
|
3
|
(4)
|
(72)
|
(69)
|
(74)
|
(88)
|
|
| Pre-Tax Income |
(31)
N/A
|
(31)
0%
|
(41)
-31%
|
(56)
-36%
|
(61)
-8%
|
(67)
-9%
|
(73)
-9%
|
(69)
+4%
|
(80)
-16%
|
(82)
-2%
|
(82)
+0%
|
(81)
+2%
|
(72)
+10%
|
(84)
-17%
|
(88)
-4%
|
(95)
-8%
|
(92)
+2%
|
(73)
+21%
|
(57)
+21%
|
(43)
+26%
|
(70)
-63%
|
(90)
-29%
|
(103)
-14%
|
(113)
-9%
|
(111)
+2%
|
(86)
+22%
|
(100)
-17%
|
(142)
-42%
|
(12)
+92%
|
(46)
-298%
|
(95)
-107%
|
(205)
-115%
|
(198)
+3%
|
(273)
-38%
|
(228)
+17%
|
(334)
-46%
|
(256)
+23%
|
(279)
-9%
|
(758)
-171%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
8
|
4
|
0
|
4
|
(2)
|
(0)
|
1
|
|
| Income from Continuing Operations |
(31)
|
(31)
|
(41)
|
(56)
|
(61)
|
(67)
|
(73)
|
(69)
|
(80)
|
(82)
|
(82)
|
(81)
|
(72)
|
(84)
|
(88)
|
(95)
|
(92)
|
(73)
|
(57)
|
(43)
|
(70)
|
(90)
|
(103)
|
(113)
|
(111)
|
(86)
|
(100)
|
(142)
|
(12)
|
(46)
|
(95)
|
(203)
|
(190)
|
(270)
|
(228)
|
(329)
|
(258)
|
(280)
|
(757)
|
|
| Net Income (Common) |
(31)
N/A
|
(31)
0%
|
(41)
-31%
|
(56)
-36%
|
(61)
-8%
|
(67)
-9%
|
(73)
-9%
|
(69)
+4%
|
(80)
-16%
|
(82)
-2%
|
(82)
+0%
|
(81)
+2%
|
(72)
+10%
|
(84)
-17%
|
(88)
-4%
|
(95)
-8%
|
(92)
+2%
|
(73)
+21%
|
(57)
+21%
|
(43)
+26%
|
(70)
-63%
|
(90)
-29%
|
(103)
-14%
|
(113)
-9%
|
(111)
+2%
|
(86)
+22%
|
(100)
-17%
|
(142)
-42%
|
(12)
+92%
|
(46)
-298%
|
(95)
-107%
|
(203)
-113%
|
(190)
+6%
|
(270)
-42%
|
(228)
+15%
|
(329)
-44%
|
(259)
+22%
|
(280)
-8%
|
(757)
-170%
|
|
| EPS (Diluted) |
-0.52
N/A
|
-0.52
N/A
|
-0.26
+50%
|
-0.91
-250%
|
-0.98
-8%
|
-1.07
-9%
|
-0.44
+59%
|
-1.11
-152%
|
-1.29
-16%
|
-1.32
-2%
|
-0.48
+64%
|
-1.17
-144%
|
-1.05
+10%
|
-0.45
+57%
|
-0.45
N/A
|
-0.39
+13%
|
-0.39
N/A
|
-0.31
+21%
|
-0.09
+71%
|
-0.08
+11%
|
-0.15
-87%
|
-0.17
-13%
|
-21.32
-12 441%
|
-0.21
+99%
|
-0.21
N/A
|
-0.17
+19%
|
-18.84
-10 982%
|
-0.27
+99%
|
-0.02
+93%
|
-8.49
-42 350%
|
-17.88
-111%
|
-3.18
+82%
|
-2.94
+8%
|
-3.45
-17%
|
-3.24
+6%
|
-4.21
-30%
|
-3.31
+21%
|
-3.59
-8%
|
-9.71
-170%
|
|
Switch to:
Switch to:
See Also
Discover More
